Tamron Co., Ltd. 2Q Earnings Preview

Sustained high growth in Surveillance & FA and Mobility & Healthcare, Photo OEM recovery, and progress on the current mid-term plan "Value Creation 26 Ver.2.0" target of launching 10+ proprietary brand new products are in focus

PublishedAugust 5, 2026 at 15:30 GMT+9

Summary

Tamron's Q1 results showed double-digit revenue and profit growth in the Surveillance & FA segment (+25.2%) and Mobility & Healthcare segment (+19.1%), beating plan. Meanwhile, the Photo segment was dragged down by continued weakness in certain OEM product lines, though the proprietary brand secured double-digit revenue growth across Japan, the US, and Europe, accelerating the 2026 product strategy of launching 10+ new models. For the 2Q results, in light of the next mid-term plan "Value Up29" (FY2029 targets: revenue ≥JPY 120B, operating income ≥JPY 25B) announced in June, along with the dividend increase and revised shareholder return policy, confirming progress on business portfolio transformation and margin recovery will be critical. Amid persistent trade policy uncertainty and cost pressures from rising raw material and labor costs, the key investment question is whether non-Photo segment growth can offset OEM revenue declines and bolster confidence in achieving the 2H-weighted full-year plan (revenue JPY 91B, +7.0%).

Key Points for Next Quarter

Key Points & Focus	Implications
Revenue GrowthProgress against the company's 1H plan of JPY 41.4B	Q1 actual of JPY 18,485M (44.6% achievement rate) exceeded plan. Whether standalone Q2 reaches JPY 22,915M (our estimate) will determine FY guidance achievability
Photo OEM RecoveryOEM order trends and Photo segment revenue	Q1 Photo revenue was JPY 11,305M (▲16.7%). If OEM weakness persists, achieving the FY revenue target of JPY 91B (+7.0% YoY) will require additional upside from non-Photo segments
Proprietary Brand New ProductsProgress on the plan to launch 10+ new products annually	As of Q1-end, A078 had been released; B070 for Canon/Nikon mount launched in Q2, with A084 announced in July. Launch pace and regional revenue contribution are key to proprietary brand growth
OPMConsolidated OPM trend YoY	Q1 was 18.6% (vs. 21.8% in the year-ago period, ▲3.2pt). Rising raw material costs, labor costs, and R&D expenses are pressuring margins. Watch for a recovery trend in Q2
Surveillance & FA / MobilityRevenue mix and profit contribution growth from non-Photo segments	Non-Photo revenue mix reached 38.8% in Q1 (vs. 30.2% in the year-ago period). Watch whether the mid-term plan's strategy of "raising each of the two non-Photo segments to 15%+ of revenue" accelerates
Mid-Term Plan / Capital PolicyKPIs and ROE levels	Consistency between the mid-term plan's ROE target of 16%+ and the current equity ratio of 82.5% and increased dividend (JPY 51/year). Focus on concrete measures to improve capital efficiency
FX ImpactGap between FX assumptions and prevailing rates	Q1 benefited from JPY weakness of +JPY 4/USD and +JPY 23/EUR. FX tailwind contributed +JPY 530M to revenue and +JPY 300M to operating income in Q1; watch for incremental impact from further yen depreciation

Key Issues from Previous Results (FY12/2026 Q1)

Q1 results came in at revenue JPY 18,485M (▲5.0%) and operating income JPY 3,441M (▲18.7%), marking a top- and bottom-line decline, though the company explicitly stated results were "tracking above plan." The dynamic of non-Photo double-digit growth partially offsetting Photo OEM weakness became clearly evident. Photo segment recovery in 2H, supported by the other two segments, will be key to plan achievement.

1. Photo Segment OEM Recovery Timing

Previous Quarter:
Revenue JPY 11,305M (▲16.7%), operating income JPY 2,390M (▲37.2%). OEM product weakness in certain models that began in 2H of the prior year persisted, dragging down segment-wide revenue and profit. The proprietary brand posted double-digit revenue growth in Japan, the US, and Europe, but China saw a decline due to excess inventory
This Quarter Focus:
Whether the OEM order trough has been reached and whether there are signs of pipeline improvement from Q2 onward. Whether new proprietary brand launches (B070, A084, etc.) combined with China inventory digestion can reverse segment revenue trajectory
Key Metrics:
Photo segment revenue YoY, segment OPM (Q1: 21.1% vs. 28.0% in the year-ago period), shifts in proprietary brand vs. OEM revenue mix

2. Surveillance & FA Segment Growth Sustainability

Previous Quarter:
Revenue JPY 3,602M (+25.2%), operating income JPY 523M (+27.9%). Double-digit revenue growth across all product categories—surveillance camera lenses, FA/machine vision lenses, camera modules, and video conferencing lenses. Impact of FA inventory normalization had run its course
This Quarter Focus:
Whether the full-fledged recovery in the FA/machine vision market continues. Whether expanding demand for high-definition, high-resolution edge AI-enabled surveillance cameras lifts lens demand
Key Metrics:
Whether segment revenue sustains double-digit growth; room for improvement from the 14.5% OPM (Q1 actual)

3. Mobility & Healthcare Segment Growth Acceleration

Previous Quarter:
Revenue JPY 3,577M (+19.1%), operating income JPY 901M (+23.7%). Automotive camera lenses posted double-digit revenue growth, driven by ADAS adoption and Chinese market recovery. Medical lenses surged approximately 1.6x YoY
This Quarter Focus:
Whether the Chinese automotive lens market recovery translates into sustainable growth. Whether the medical lens surge reflects base effects or structural demand expansion. Whether advancing ADAS sensing technology (multi-camera systems, higher resolution) drives further order growth
Key Metrics:
Segment revenue YoY growth rate, medical lens revenue levels, maintenance/improvement of the 25.2% segment OPM (Q1 actual)

4. Cost Structure and OPM Recovery

Previous Quarter:
Gross profit margin 44.4% (vs. 45.8% in the year-ago period, ▲1.4pt), SG&A JPY 4,767M (+2.0%). Rising raw material and utility costs, wage inflation, and increased R&D spending pressured profitability. OPM at 18.6% (vs. 21.8% in the year-ago period)
This Quarter Focus:
Whether cost reduction and productivity improvement initiatives begin to materialize in Q2. Whether the rising revenue share of non-Photo segments contributes to improved overall business mix. Pace of depreciation expense growth (Q1: JPY 852M vs. JPY 745M in the year-ago period, +14.4%)
Key Metrics:
Gross profit margin YoY change, quarterly OPM trend, achievability of 1H cumulative operating income of JPY 7,700M (18.6% OPM)

5. Next Mid-Term Plan "Value Up29" and Capital Policy

Previous Quarter:
Outline of "Value Up29" announced in June. Quantitative targets set at FY2029 revenue ≥JPY 120B and operating income ≥JPY 25B, with a long-term vision of FY2035 revenue ≥JPY 200B and ROE ≥20%. Shareholder return policy revised to the higher of 60% payout ratio or 8% DOE. Concurrently, FY12/2026 annual dividend forecast raised from JPY 37 to JPY 51, implementing a dividend increase under the current mid-term plan's return policy of "60% total return ratio" while committing to stable and enhanced profit returns under the new plan
This Quarter Focus:
Detailed commentary on each segment's strategy. Concrete monetization timeline for new businesses (metasurface near-infrared light source, etc.). Whether M&A or strategic investments take shape
Key Metrics:
ROE levels (shareholders' equity of JPY 84,861M at Q1-end), post-increase dividend yield and total return ratio, capex and R&D spending plans

Timely Disclosure & Industry Trends

2026/07/15
Announced launch of ultra-wide-angle zoom lens "12-20mm F2.8 (A084)" for Sony E-mount/Nikon Z-mount — A high-value-added full-frame lens aligned with the target of 10+ new product launches per year. Slated for August release, limiting direct Q2 contribution, but expected to boost proprietary brand revenue from Q3 onward Ultra-wide-angle zoom lens "12-20mm F2.8 (Model A084)" for Sony E-mount and Nikon Z-mount launch
2026/06/24
Launched APS-C standard zoom "17-70mm F2.8 (B070)" for Nikon Z-mount/Canon RF-mount — Expanding the third-party lineup for Canon RF-mount directly broadens sales opportunities. July release partially contributing to Q2 revenue Class-leading zoom range large-aperture standard zoom lens 17-70mm F2.8 (Model B070) for Nikon Z-mount and Canon RF-mount launch
2026/06/19
Successfully commercialized metasurface near-infrared light source — Joint research outcome with Osaka University. Sample shipments beginning fall 2026, with expansion into new business domains including medical, food, and infrastructure inspection anticipated World's first successful commercialization of a heat-resistant chip-type "metasurface near-infrared light source using MIM structure"
2026/06/16
Announced outline of next mid-term plan "Value Up29" and dividend increase — Simultaneously disclosed quantitative targets of FY2029 revenue ≥JPY 120B and operating income ≥JPY 25B, annual dividend increase to JPY 51 (from JPY 37), and revised return policy (higher of 60% payout ratio or 8% DOE). A significant disclosure balancing medium- to long-term growth strategy with enhanced shareholder returns Notice regarding renewal of long-term vision quantitative targets and formulation of next mid-term management plan "Value Up29" outline

Previous Quarter Results (FY12/2026 Q1 Actual)

Tamron operates across three segments centered on optical lens design and manufacturing: Photo (proprietary brand interchangeable lenses and OEM), Surveillance & FA (surveillance camera and machine vision lenses, etc.), and Mobility & Healthcare (automotive camera and medical lenses, etc.). For FY12/2026, the company targets full-year revenue of JPY 91B (+7.0%) and operating income of JPY 18.5B (+11.2%), premised on a 2H-weighted earnings structure. Q1 saw Surveillance & FA and Mobility & Healthcare exceed plan, while Photo OEM weakness weighed on the overall result. Backed by a robust equity ratio of 82.5%, the company has committed to balancing growth investment and enhanced shareholder returns under the mid-term plan "Value Up29."

Item	Amount	YoY	vs. Company Plan	Remarks
Revenue	JPY 18,485M	▲5.0%	- (Note)	Primarily driven by Photo OEM decline. Non-Photo segments posted double-digit revenue growth
Operating Income	JPY 3,441M	▲18.7%	- (Note)	OPM 18.6% (vs. 21.8% in the year-ago period). Higher raw material, labor, and R&D costs
Recurring Profit	JPY 3,363M	▲20.6%	- (Note)	Recorded JPY 186M FX loss
Quarterly Net Income	JPY 2,712M	▲4.5%	- (Note)	Year-ago period included JPY 407M loss on sale of investment securities
EPS	JPY 16.82	▲3.6%	-	-

(Note) The company does not disclose standalone Q1 plan figures but explicitly stated results were "tracking above plan." Q1 achievement rate against the 1H plan (revenue JPY 41.4B) was 44.6%

Guidance Achievement Rate for Full Year: Revenue 20.3% (vs. 22.9% in the year-ago period), operating income 18.6% (vs. 25.5% in the year-ago period). Broadly in line with expectations given the 2H-weighted plan structure

Disclaimer

ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.

Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.

Tamron Co.,Ltd.